Bendamustine in Acute Lymphoblastic Leukemia/Lymphoma (ALL)
NCT01649622
·
clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Conditions
Leukemia
Lymphoma
Interventions
DRUG:
Bendamustine
Sponsor
M.D. Anderson Cancer Center